{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T11:16:15Z","timestamp":1697282175203},"reference-count":21,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T00:00:00Z","timestamp":1216252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2003<\/jats:bold> A mutation of Janus kinase 2\u00a0V617F is present in most patients with polycythaemia vera (PV). However, it is generally believed that JAK2<jats:sup>V617F<\/jats:sup> is not the sole molecular abnormality in PV. Since dasatinib is currently evaluated in patients with PV, it is of interest to study the effects of dasatinib on the growth of clonal progenitor cells <jats:italic>in vitro<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Design and methods\u2003<\/jats:bold> Peripheral blood mononuclear cells from patients with PV, chronic myeloid leukaemia (CML) and controls were exposed to dasatinib (0\u00b71 to 500\u00a0n<jats:sc>m<\/jats:sc>\u00a0mL<jats:sup>\u22121<\/jats:sup>). Colony growth was stimulated by interleukin\u20103, granulocyte\u2010macrophage colony\u2010stimulating factor and erythropoietin. Endogenous erythroid colony (EEC) growth was investigated without exogenous cytokines. Real\u2010time PCR was performed to assess the percentage of JAK2<jats:sup>V617F<\/jats:sup> cells.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> 10\u00a0n<jats:sc>m<\/jats:sc> of dasatinib suppressed EEC growth from PV by 89% (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7002). This inhibition was dose dependent and occurred at pharmacological concentrations. Erythroid and myeloid colony growth was also significantly suppressed in the presence of exogenous cytokines. When compared to PV the inhibition of stimulated colony growth was significantly less pronounced in controls but tended to be more vigorous in CML. Interestingly, despite the potent inhibition of PV cells real\u2010time PCR revealed that the numbers of JAK2<jats:sup>V617F<\/jats:sup> transcripts did not decrease upon exposure to dasatinib.<\/jats:p><jats:p><jats:bold>Conclusion\u2003<\/jats:bold> This study shows a marked inhibition of the proliferative capacity of progenitor cells from PV. Although JAK2<jats:sup>V617F<\/jats:sup> transcript levels did not decrease upon exposure to dasatinib, the drug might suppress PV progenitors through inhibition of a yet undefined molecular target.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2008.01982.x","type":"journal-article","created":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T22:14:55Z","timestamp":1216332895000},"page":"578-584","source":"Crossref","is-referenced-by-count":8,"title":["Dasatinib inhibits progenitor cell proliferation from polycythaemia vera"],"prefix":"10.1111","volume":"38","author":[{"given":"M.","family":"Wappl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Streubel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gisslinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Schwarzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Valent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,17]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-005-0047-7"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-009605"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03041036"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/shem.2001.23043"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-942754"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1199"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.023"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-009605"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.11.012"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0676"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402938"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099480"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049486a"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2006.01645.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-017392"},{"key":"e_1_2_7_19_2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V89.4.1147","article-title":"Interleukin\u201010 inhibits spontaneous CFU\u2010GM growth from human peripheral blood mononuclear cells by suppression of endogenous GM\u2010CSF release","volume":"89","author":"Oehler L","year":"1997","journal-title":"Blood"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1112"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607313150503"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","unstructured":"ZaleskasVM KrauseDS LazaridesK PatelN HuY LiS Van EttenRA.Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2V617F.PLoS ONE2006;1:e18.","DOI":"10.1371\/journal.pone.0000018"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2008.01982.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2008.01982.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:19:25Z","timestamp":1697177965000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2008.01982.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,17]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1365-2362.2008.01982.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2008.01982.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,17]]}}}